Billing

NeoGenomics is a participating provider with Medicare and Medicaid, in addition to many private insurance providers and managed care organizations.

NeoGenomics clients receive an itemized invoice that includes the date, patient’s name, accession number, test(s) performed, and test fees for each specimen completed during a given month. Please note that these invoices are payable upon receipt. If you have any questions pertaining to your account, please contact our Billing team immediately so that we may resolve them in a timely manner.

For providers who choose third-party billing, NeoGenomics will bill the patient’s insurance provider in accordance with their healthcare plan. We will work closely with your office to obtain the necessary medical documentation, including ICD-10 codes, and handle all appeals to minimize the impact for your patient.

BCRABL, JAK2, CALR, MPL
MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease

InVisionFirst 
MolDX: Inivata^™, InVisionFirst^®, Liquid Biopsy for Patients with Lung Cancer

BRAF
MolDX: FDA-Approved BRAF Tests

KRAS
MolDX: FDA-Approved KRAS Tests

EGFR
MolDX: FDA-Approved EGFR Tests

NGS for Solid Tumors
MolDX: Next-Generation Sequencing for Solid Tumors

NRAS 
MolDX: NRAS Genetic Testing

Flow Cytometry
Lab: Flow Cytometry

Cytogenetics
CMS Manual System
NCD190.3 Cytogenetics Studies

Honoring the 14-day rule

Good faith estimate

Billing and Coding details for Myeloid Disorders

Prior authorization support for molecular & genetic testing

Molecular and genetic testing is an evolving field in oncology diagnostics, and many insurance providers have established a policy of prior authorization before testing can be performed to ensure appropriate use. NeoGenomics contracts with many national and regional healthcare insurance plans to help offer affordable testing to our patients and clients; however, each insurance plan may have a different process for obtaining prior authorization for testing.

For more specific information, NeoGenomics recommends calling the patient’s insurance plan for their current policy. For any questions or prior authorization support, please email 
priorauthorizations@neogenomics.com.

Pay my bill

NeoGenomics is committed to working with patients and their insurance providers to ensure that everyone has access to high-quality cancer testing.

We believe that all patients, regardless of socioeconomic status, ethnicity, or race, should have the same access to care. This is why NeoGenomics is proud to be in-network with hundreds of national health insurance providers and programs, covering over 300 million lives in the United States.

NeoGenomics partners with patients to ease the financial burden of testing. If you receive a denial letter, or if you are interested in financial assistance or in setting up a payment plan, please contact us.

Testing at NeoGenomics – what to expect 

Good faith estimate

Financial Assistance Application (English)

Financial Assistance Application (Spanish)

We believe that every patient should have access to the best possible cancer care. We have a dedicated support team to assist with insurance appeals, prior authorizations, and financial assistance including interest-free payment plans. Both insured and uninsured patients may qualify for no-cost or reduced-cost testing through our billing resource programs. We also offer prompt-pay discounts and payment plans.

Our online financial assistance application is currently unavailable, but you can still apply using the forms below. If you need assistance, please contact our Billing specialists at 866.776.5907, Option 2.

You can also apply by mail. Simply download, print, and complete your application and mail it to:

NeoGenomics Laboratories, Inc. 
P.O. Box 947586 
Atlanta, GA 30394-7586

Financial Assistance Application (English)

Financial Assistance Application (Spanish)

Once your application is received, a Patient customer service representative will contact you within 48 hours.